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Abstract.  We previously identified a 90-kD (GP90), 
collagen-binding, membrane glycoprotein, termed ex- 
tracellular matrix receptor 1II (ECMR HI), that is ho- 
mologous to the lymphocyte homing receptor and 
CD44 antigen (Gallatin, W. M., E. A. Wayner, P. A. 
Hoffman, T. St.  John, E. C.  Butcher, and W. G. 
Carter.  1989. Proc.  Natl.  Acad.  Sci.  USA. 
86:4654-4658).  CD44 is abundantly expressed in 
many epithelial tissues, and is localized predominantly 
to filopodia in cultured keratinocytes. Here we estab- 
lish CD44 as a polymorphic family of related mem- 
brane proteoglycans and glycoproteins possessing ex- 
tensive diversity in both glycosylation and core protein 
sequence. Human neonatal foreskin keratinocytes 
(HFKs) and QG56 lung squamous carcinoma cells ex- 
press an alternatively spliced form of the CD44 core 
protein (termed CD44E) that contains an additional 
132 amino acids in the carbohydrate attachment region 
of the extracellular domain. HFKs, HTI080 fibrosar- 
coma and QG56 cells, as well as many other human 
cells, contain varying ratios of GP90 and structurally 
related, higher molecular mass forms of CD44 that 
express the following characteristics: (a) each form 
reacted with anti-CD44 (mAbs) P1G12, P3H9,  and 
P3H5. Each of these mAbs recognized a distinct, 
nonovedapping epitope present on each CD44 form. 
(b) Differences in mass were due primarily to varia- 
tion in carbohydrate moieties, including sulfated 
aspargine-linked glycopeptides (GP), chondroitin sul- 
fate (CS), and heparan sulfate (HS) glycosaminogly- 
cans, as well as O-linked mucin and polylactosamine 
structure(s). The major polymorphic forms were 
designated HT1080 GP90 and CS180,  QG56 GP230, 
and HFK HS/CS250, based on dominant carbohydrate 
moieties and relative mass. (c) The polymorphic forms 
use CD44 and CD44E core proteins, each containing 
a unique set of potential attachment sites for O- and 
N-glycosides and glycosaminoglycans. (d) Im- 
munofluorescence microscopy, differential extraction 
with Triton-X-114 detergent, and incorporation into 
liposomes indicated that all the forms were membrane 
bound glycoconjugates. These results define CD44 as 
a structurally diverse, but immunologically related, set 
of intrinsic membrane macromolecules, and suggests 
that these structurally varied forms might be expected 
to manifest multiple functions. 
T 
HE polymorphic family of integral membrane glyco- 
proteins CD44 (see Haynes et al., 1989 for review) is 
found on a wide variety of cells. The exact function(s) 
of CIM4 has yet to be conclusively defined, although recent 
reports have implicated CIM4 in lymphocyte  homing (Jalka- 
nen  et  al.,  1987), lymphohemopoiesis (Miyake  et  al., 
1990a) and T cell activation (Shimizu et al., 1989; Huet et 
al.,  1989). The widespread distribution  of CD44 in non- 
hemopoietic cell types (Carter and Wayner, 1988; Flanagan 
et al.,  1989), however, argues for a more general function 
than those delegated to it in the hemopoietic lineage. Previ- 
ously reported biochemical and cell biological properties are 
consistent with a role as an adhesive cell-surface glycopro- 
tein. CD44 may function either by linking extracellular ma- 
trix proteins such as collagen (Carter and Wayner, 1988) or 
hyaluronic acid (Miyake et al.,  1990b; Aruffo et al.,  1990) 
with the cytoskeleton (Carter and Wayner, 1988; Kalomiris 
and Bourguignon,  1988), or may be involved with homo- 
typic (St. John et al., 1990; Belitsos et al., 1990) or hetero- 
typic (Shimizu et al., 1989; King et al., 1990) intercellular 
adhesion. 
Most studies have concentrated on the 80-90-kD form of 
CD44 in hemopoietic cells. Before the CD44 classification, 
it was referred to by several designations, including extracel- 
lular matrix receptor HI (ECMR III; Wayner and Carter, 
1987; Carter and Wayner, 1988), phagocytic glycoprotein 1 
(Pgp-1; Isacke et al., 1986), the hyaluronate receptor (Alho 
and Underhill, 1989; UnderhiU, 1989), p80 (Haynes et al., 
1983), p85 (LeTarte et al.,  1985), or antigens of the mAbs 
F-10-44-2 (Dalchau et al., 1980), Hermes-1 (Jalkanen et al., 
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using a host of monoclonal antibodies have verified immuno- 
logically that these molecules are very similar, if not identi- 
cal, entities (Gallatin et al.,  1989; Picker et al., 1989; Omary 
et al.,  1988; Pals et al.,  1989; Lesley et al.,  1990). The pre- 
dominant mRNA transcripts of CD44 in baboon (Idzerda et 
al.,  1989) and human (Stamenkovic et al.,  1989; Goldstein 
et al.,  1989) lymphoid cells codes for a 37-kD core protein 
with 75,  5,  and 20%  of the polypeptide designated  as ex- 
tracellular,  transmemhrane,  and cytoplasmic  domains,  re- 
spectively.  The  NH2-terminal  portion  of the  extracellular 
domain has an '~30%  homology to mouse link protein,  a 
hyaluronic acid and collagen binding protein which  stabi- 
lizes large aggregates of proteoglycan core proteins in carti- 
lage  (Neame et al.,  1987).  This protein core of CD44 is 
modified by extensive N- and O-glycosylation to an 80-90- 
kD form or by addition of chondroitin sulfate to a 180-200- 
kD form (Carter and Wayner,  1988;  Gallatin et all.,  1989; 
Jalkanen,  1988;  Stamenkovic  et al.,  1989;  Omary  et al., 
1988). 
In this report we have investigated the structural aspects 
of the higher  molecular mass  forms,  particularly  in non- 
hematopoietic  cells.  We characterized four of these forms 
from three different cell populations,  with particular atten- 
tion to human neonatal  foreskin keratinocytes  (HFKs)?  a 
cell population that expresses particularly high quantities of 
CIM4 in tissue (Carter et al.,  1990a). The major form of 
CD44 expressed by HFKs, termed HS/CS250,  is identified 
as  a  membrane  heparan  sulfate/chondroitin  sulfate  pro- 
teoglycan  and was localized  to filopodia  and intercellular 
contacts. 
Materials and Methods 
Materials 
PMSF, N-ethylmaleimide,  2-mercaptoethanol, BSA, Triton X-100 and Tri- 
ton X-l14 detergents,  n-octyl-~-v-glucopyranoside detergent, ethylenedi- 
aminetetraacetic acid,  protein A-agarose,  egg  yolk phosphatidylchuline, 
were purchased from Sigma Chemical Co. (St. Louis, MO). Random hex- 
amer and oligo dTl2 were obtained from Pharmacia Fine Chemicals (Pis- 
caraway, NJ). Pronase and lactoperoxidase  were from Calbiochem-Behring 
Corp.  (La Jolla, CA). Fluorescein-conjugated  (8oat) anti-mouse IgG and 
IgM (H and L chains) and rhodamine-conjugated  (goat) anti-rabbit IgG 
were obtained from Tago, Inc. (Burlingame,  CA). Rabbit anti-mouse IgG 
(H+L) antiserum was obtained from Cappel Laboratories (Cooper Bio- 
medicals,  Malvern, PA).  [35S]H2SO4 (carrier-free)  and [35S]methionlne 
(Tram 35S-label, 1,010 Ci/mmol) were from ICN Radiochemicals  (Cleve- 
land, OH). Enligbtnin$o=  [¢-32p]deoxycytidine tripbosphate  (3,000 Ci/mmol) 
and 3H-pbosphatidylcholine  were purchased from New England Nuclear 
(Wilmington, DE). 125I  and [ct-35S]deoxyadenosine  thiotripbosphate  (>1,000 
Ci/mmol) was  from Amersham Chemical Co.  (Arlington Heights,  IL). 
Wheat germ aSglutinin  (WGA) was  obtained from Vector  Laboratories 
0Burlingame, CA) and was coupled to CNBr-activated  Sepharose (Parikh 
et al.,  1974).  Glycosidases  and DNA-modifying  enzymes,  unless noted 
elsewhere, were obtained from Boehringer Mannheim Biochemicals  (Indi- 
anapolis,  IN). 
Cells, Cell Culture, Tissue 
Normal newborn HFKs  were prepared as described by Boyce and Ham 
(1985).  Cultures were maintained in serum-free keratinocyte  growth me- 
dium (KGM; Clonetics,  San Diego, CA).  Normal embryonic human lung 
diploid fibroblasts, WI-38 cells, BT-20 human breast carcinoma, and a hu- 
1. Abbreviations used in this paper: HFF, human dermal fibroblasts;  HFK, 
human foreskin fibroblasts. 
man fibrosarcoma,  HT1080, were obtained from the American 1~ype Cul- 
ture Collection (Rockville,  MD). QG-56 (squamous  cell carcinoma of the 
lung) was obtained from Dr. San-itiroh Hakomori (The Biomembrane  Insti- 
tute, Seattle, WA). These cell lines were grown as adherent monolayer cul- 
tures in RPMI 1640 supplemented with 10% FBS. 
Human lympbokine-activated  killer (LAK) cells were grown from pe- 
ripheral blood lymphocytes  (PBL) as described (Grimm et al.,  1982) in 
Click's medium supplemented with 10% FBS and 500--1,000 U/rul IL2. All 
other lymphoid tumor cell lines: Molt 4 (T cell leukemia), HL-60 and U937 
(promonocyte  cell lines), and Daudi (Burkitt's  lymphoma) were obtained 
from Dr. David Urdal (Immunex Corp., Seattle, WA). Primary spleen cells, 
the EBV transformed human B lymphocyte cell line ST-l, and PHA stimu- 
lated T lymphocytes  were prepared as previously described (Wayner and 
Carter, 1987; Wayner et al., 1988). CLL is a chronic T lymphocyte leuke- 
mia derived from a patient in blast crisis. Manka cells are a human Burkitts 
lympboma. 
Preparation of  Monoclonal and Polyclonal  Antibodies 
Anti-CD44 mAbs (P3H9, P3H5,  and P1G12) were prepared as previously 
described (Wayner and Carter,  1987).  mAbs PIG12, P3H9, and P3H5 all 
reacted with nonoverlapping epitopes on CIM4 as determined by competi- 
tive binding studies  (Gallatin et al.,  1989). 
Rabbit polyclonal antibodies against human fibronectin  were prepared as 
previously described (Carter,  1982). Rabbit polyclonal antibodies Were  pre- 
pared against mouse laminin isolated from mouse EHS sarcoma.  Rabbit 
polyclonal  antiserum against involucrin, a component of the keratinocyte 
envelope (Rice and Green, 1979), was a gift from Dr. Robert Rice (Univer- 
sity of California, Davis, CA). Rabbit polyclonal antibodies (Ab33; Roman 
et al., 1989) against integrin c~5 were from Dr. John McDonald (Washing- 
ton University, St. Louis,  MO). Rabbit polyclonal antiserum against type 
I collagen was from Chemicon International, Inc.  (El Segundo, CA). 
Metabolic Labeling, Pulse-Chase Experiments, 
and PAGE 
Metabolic labeling with 35SO4  -2 or with [3SS]methionlne or pulse-chase 
studies using [35S]methionlne were performed essentially as described pre- 
viously  (Carter and Wayner,  1988). 
Polyacrylamide  slab gels containing SDS (SDS-PAGE gels) were pre- 
pared following  the basic stacking gel system  of Laemmli (1970).  Pre- 
stained protein standards for relative molecular mass estimation were ob- 
tained from either Bethesda Research  Laboratories (Bethesda,  MD) or 
Sigma Chemical Co.  (St.  Louis, MO).  Protein concentration was deter- 
mined by the fluorescamine  method using BSA as standard (Udenfriend et 
al.,  1972). 
Nitrous Acid Cleavage  of  Heparan Sulfate 
Triton X-100 extracts  of 3sSO4-2-1abeled I-IFKs or QG56 cells were im- 
mune precipitated with P3H9 to isolate radiolabeled CD44. The selective 
removal of heparan sulfate by the method of Shively and Conrad (1976) was 
performed as described by David and Van den Berghe (1985), except incu- 
bations were performed for 0, 15, or 60 rain. Cleavage products were ana- 
lyzed by SDS-PAGE. The selectivity of this method was confirmed by the 
insensitivity of the QG56 GP230 form (which lacks significant heparan sul- 
fate addition) to cleavage relative to the HFK HS/CS250  form. 
Immunofluorescence, Interference Reflection, 
and Antibody-Exclusion Microscopy 
Cells were adhered to coverslips  as described (Carter et al.,  1990a) and 
were incubated with combinations of mouse or rat mAbs and rabbit poly- 
clonal primary antibodies and processed for visualization  by two-color 
fluorescence,  interference reflection  or antibody exclusion microscopy  as 
previously described (Carter et al., 1990a). Interference reflection micros- 
copy  (IRM) was performed basically as described (Izzard  and Lochner, 
1976) and was used to identify focal adhesions (FAs) in the same field as 
the two color fluorescence.  FAs were also localized by the antibody exclu- 
sion technique (Neyfakh et al.,  1983; Carter et al.,  1990a). 
Fluorescence  Microscopy of Tissue Sections 
The distribution of receptors and ligands  in tissue were  determined by 
immunofluorescence  microscopy  of 6-~m cryostat sections  as previously 
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maldehyde in PBS before incubation in primary antibodies and peroxidase- 
conjugated secondary antibodies. The samples were examined with a Zeiss 
fluorescence microscope and photographed with Kodak T-Max film at ASA 
800. In control  experiments,  no fluorescence of rhodamine  was detected 
using the fluorescein filters or vice versa. 
PCR Amplification 
The isolation  of poly-A  + RNA from primary  HFKs,  dermal  fibroblasts 
(HFFs),  and the human cell lines HT1080 or QG56 was as described by 
Badley et al.  (1988). Two micrograms  of poly-A  + RNA was transcribed 
into eDNA  by reverse transeriptase using either random hexamer oligomers 
or oligo (dTh2 as primers and cDNAs were purified by gel exclusion chro- 
matography  (BioGel  ASm;  Bio-Rad  Laboratories,  Richmond,  CA). 
Purified  eDNA was amplified by polymerase  chain reaction  (PCR)  in a 
DNA thermal  cycler  (Perkin-Elmer  Cetus  Corp.,  Norwalk,  CT)  using 
Thermus aquaticus  (Taq) DNA polymerase  and oligonucleotide  pairs  as 
noted in the text (see Fig.  8 A for an oligonueleotide map).  Other buffer 
components were as described by the enzyme supplier (Perkin-Elmer Cetus 
Corp.).  Reaction conditions were as follows: 4 rain at 940C followed by 35 
cycles of 1 rain at 940C, 2 rain at 500C and 4 rain at 72"C. The reaction 
products obtained  by PCR were separated by agarose gel electrophoresis; 
individual bands were excised and the eDNA isolated by the freeze/squeeze 
method (Tautz and Renz,  1983). 
D NA Sequencing and A nalysis 
Double-stranded eDNA for sequencing was obtained by a second round of 
PCR amplification using the purified  eDNA from the first round as tem- 
plate.  DNA was purified by gel electrophoresis,  as described  above, and 
used  directly  for sequencing  by  the dideoxy  chain  termination  method 
(Sanger et al., 1977), using a modified T7 DNA polymerase  (Sequenase; 
U. S. Biochemical Corp., Cleveland, OH) and the modification of Winship 
(1989). Primers  were annealed to the DNA by snap cooling from 100°C 
into dry ice, and included D1, B'/-6, HE1, and SJ1 oligonucleotides (see Fig. 
8 A). Both strands from at least three independent,  primary PCR reactions 
were amplified and sequenced to check and correct for possible spontane- 
ous mutations caused by Taq DNA polymerase  (Ennis et al., 1990). DNA 
sequence analysis was performed  with Genepm sot~are (Riverside Sci- 
entific, Seattle, WA). 
Northern Blot Analysis 
Northern  blot analysis of formaldehyde-treated,  size fractionated poly-A  + 
RIgA was, with slight modification, as described by Selden (1989). Hybrid- 
ization probes were either derived  from eDNA clones or synthesized by 
PCR,  tailored  for use  (if necessary)  by restriction  digestion  and  subse- 
quently purified by elution of the appropriate  band following agarose gel 
eleetrophoresis.  Probes were labeled with 32p by extension of random hex- 
amer primers using Klenow fragment of DNA polymerase I in the presence 
of [alpha-32P]dCTP (Feinberg and Vogelstein, 1983). Molecular sizes were 
determined relative to ethidium bromide-stained  molecular mass markers 
(Bethesda Research Laboratories). 
Results 
Expression of CD44 in Epithelial Tissue 
and Cultured Cells 
Localization of CD44 in cryostat sections of human tissue, 
particularly  epithelium,  identified  extensive expression  in 
many nonhematopoietic cells. In neonatal foreskin (Fig.  1), 
CD44  was preferentially  expressed  around  the  entire  pe- 
riphery of epidermal cells in the basal and spinous layers. 
CD44  was  differentially  expressed  and  decreased  in  the 
stratified  layers  subsequent to  expression  of involucrin,  a 
l~gure L  Localization of CIM4 on basal, 
lateral, and apical surfaces of epithelial 
cells in eryostat sections of  human neona- 
tal foreskin, fetal skin, and fetal lung. (A 
and B, same field, foreskin) Anti-CIM4 
(A, mAb P3H9) stains entire epidermal 
cell periphery in basal, and spinons lay- 
ers but is absent from granular layers that 
stain  with  anti-involucrin (B).  Arrows 
identify the same points in the two fields 
and distinguish the stainin$ of CD44 and 
involucrin.  (C and D,  same field, fetal 
skin) Anti-CD44 (C) in epidermis and 
dermis while anti-fibronectin (D) local- 
izes only in dermis. (Eand F,, same field, 
fetal lung) Anti-CD44 (D) strong stain- 
ing in developing bronchiol epithelium 
that is surrounded by laminin (F) in the 
basement membrane. Bar: (A-F) 40 ~,m. 
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 component of the keratinocyte envelope (Rice and Green, 
1979;  compare Fig.  1, A and B). In fetal skin (Fig.  1 C), 
CIM4  was  expressed  in both the epidermis and dermis, 
whereas fibroneetin was expressed in only the dermis (Fig. 
1 D). In human fetal lung (Fig.  1 E),  CD44 was also ex- 
pressed around the entire periphery of cells in developing 
bronchial epithelium surrounded by the laminin containing 
basement membrane (Fig.  1 F). 
CIM4 antigens, detected by immunofluorescent micros- 
copy in cultured keratinocytes, were localized to the cell sur- 
face in HFKs (Fig. 2). Although CIM4 was distributed over 
the entire cell surface, it was clearly increased in concentra- 
tion in filopodia present on the apical surface of cells and at 
the periphery of cells where they contact the substrate (Fig. 
2 B). The concentration in filopodia, however,  was distinct 
from stable cell attachment sites such as focal adhesions 
(Burridge et al., 1988; Carter et al., 1990a). CD44 was not 
detected in focal adhesions of cells attached to collagen, 
laminin or fibronectin. In contrast, integrins o~5/31 (Fig. 2 C) 
and ¢x2/31, ¢x3/31 (Carter et al.,  1990a,b)  were readily de- 
tected in elevated concentrations in focal adhesions of many 
cells. Negligible CIM4 was found  in the extracellular matrix. 
In cultures of HFK cells that had been induced to aggre- 
gate by growth in the presence of Ca  2+, CD44 concentrated 
in sites of cell-cell contact (Fig. 2 A), suggesting that it may 
be involved in cell-cell adhesion. This function would be 
consistent with the known relationship between CD44 and 
homotypic cell aggregation. 
Identification of Polymorphic Forms of CD44 
We have previously identified three mAbs, P1G12, P3H9, 
Figure  3.  Polymorphism in 
CD44 expressed by different 
cell populations. Triton X-100 
detergent extracts of the indi- 
cated  cell  populations  (HTI080, 
QG56, etc., 75 #g protein per 
ceil extract), were fractionated 
by SDS-PAGE and immuno- 
blotted with monoclonal anti- 
body P1GI2 against CD44. 
and P3H5 that react with distinct epitopes On the GP90 form 
of CD44 antigen from HT1080,  human fibrosarcoma cells 
(Carter and Wayner, 1988). We have used these mAbs in im- 
munoblotting  experiments  to  establish  that  different cell 
populations express one or more distinct molecular mass 
forms of CD44, ranging from 80 to >250 kD (Fig. 3). All 
three mAbs identified the same forms of CD44 in each cell 
population, indicating that all the forms expressed the same 
nonoverlapping epitopes. 
All the forms detected by immunoblotting  or in subsequent 
immunoprecipitation experiments migrated as broad diffuse 
bands on SDS-PAGE suggesting a high degree of  posttransla- 
tional modification, such as phosphorylation and/or glycosy- 
lation (Carter and Wayner, 1988): (a) HT1080 fibrosarcoma, 
U937 premonoeyte and ST-1 Epstein-Barr virus-transformed 
B lymphocytes all expressed at least two forms of CD44 
migrating with relative molecular masses of ,,o90 and 180 
kD. In general the 180-kD form was always present in minor 
quantities relative to the 90-kD form. (b) QG56 lung carci- 
noma (230 kD), neonatal HFKs (180 and 250 kD), and BT- 
20 breast carcinoma (120 kD), expressed the indicated higher 
molecular mass forms as the predominant species, with rela- 
tively lower quantities of the 90-kD forms detected. In con- 
trast some cells such as Molt 4, T cell lymphoma, and Daudi, 
a Burkitts lymphoma expressed no detectable CD44 under 
these conditions. 
Characterization of Sulfated and Nonsulfated 
Carbohydrates on CD44 
We investigated carbohydrate diversity as a possible source 
of CD44 polymorphism. First, we examined the CD44 anti- 
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 l~gure  5. Effects  of  neuraminidase  digestion  on lectin  binding  to HT1080 GP90 and QG56  GP230. Purified  GP90 from HT1080 cells and GP230 
from QG56 cells were fractionated by SDS-PAGE (8%) then electrophoretically transferred to nitrocellulose. The nitrocellulose-bound 
glycoproteins  were incubated with (+) or without (-) neuraminidase, then incubated with ~2SI-labeled  lectins or antibodies followed  by ~2sI- 
labeled protein A. Antibodies and lectins bound to the glycoproteins  were detected by autoradiography. 
gens for the presence of  high molecular mass sulfated carbo- 
hydrates. The presence of extensive sulfation on the multiple 
forms of CD44  was determined by metabolic labeling of 
HTI080, QG56 and HFK cells with 3sSO4  -2 followed by im- 
munoprecipitation of the  labeled  cell  extracts  with mAb 
P1G12 (Fig. 4).  To facilitate identification of the forms of 
CD44, we referred to each form on the basis of the relative 
molecular mass and the dominant carbohydrate moieties de- 
tected by enzyme digestion. The results are summarized as 
follows:  (a) digestion of the 90-kD form from HT1080 cells 
(Fig. 4, HT/080) with glycopeptide-N-glycosidase removed 
'~50% of the sulfate label associated with the 90-kD form 
resulting in a higher mobility form labeled *GP90. None of 
the other enzymes had a significant effect on the degree of 
sulfation and/or migration. Therefore, the only detectable 
form of carbohydrate sulfation associated with the 90-kD 
form is sulfated asparagine-linked glycopeptides (GP). This 
form shall be referred to as HTI080 GP90. Unsulfated, O-gly- 
cosidically linked mucin carbohydrates were also detected 
on GP90 by digestion with glycopeptide-O-glycosidase, af- 
ter neuraminidase treatment, and a corresponding increase 
in migration of the GP90 resulted (not shown). The presence 
of  enzyme-resistant  sulfate on both HT1080 GP90 and QG56 
GP230  suggests possible peptide sulfation.  (b)  Sulfate as-  ' 
sociated with HT1080  (180-kD  form) was completely re- 
moved by digestion with chondroitinase ABC but was un- '~ 
aff~ted by the other enzymes. Thus, all the sulfate is in the 
form of chondroitin sulfate (CS)  and this form shall be re-, 
ferred to as HTI080 CS180. (c) None of the enzymes, either 
individually (Fig. 4, QG56) or in combination (results not 
shown) removed' >60 % of the sulfate from the 230-kD form 
in QG56 cells. However, both heparitinase and glycopeptide- 
N-glycosidase released ,x,20-30 % of the label from the core 
protein with a corresponding increase in the band migration, 
labeled *GP230.  This suggests that the 230-kD form con- 
tains a minor percentage of the covalently bound sulfate in 
the form of heparan sulfate and sulfated asparagine4inked 
carbohydrates ah~t shall be referred to as QG56 GP230.  Im- 
mune pp~,cipitation of CD44 from conditioned culture me- 
dium of l~KJ56 (Fig.  4,  QG56, Medium) and  HFKs (not 
show~ biit not HT1080 cells, detected released-forms of  the 
CD44 antigens. The released forms comigrated with the cel- 
lular forms of the antigens from each cell type.  Enzyme 
digestion of the released forms gave similar results as the cel- 
lular forms. The released form of GP230 contained a high 
molecular weight component, designated "HEP~' that copre- 
cipitated with GP230 and was completely degraded by the 
heparitinase. Various dissociation experiments failed to re- 
move HEP from the immunoprecipitates, suggesting that it 
is a  higher molecular mass form of CD44 with extensive 
heparan sulfate additions. (d) Mos  t of the sulfate associated 
with the 250-kD  forms of CD44' from HFK cells was re- 
moved by digestion with heparitinase (Fig. 4, HFK, Cell) or 
by a 15-min incubation with nitrous acid (not shown, Shively 
and Conrad,  1976).  The minor amount of label associated 
with the heparitinase-resistant core was removed by diges- 
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 Figure 7. Northern  blot analysis  with different  CIM4 probes using  poly-A  +  RNA from four  cell populations. Poly-A  +  RNA from HTI080, QG56, 
HFK, and HFF cells (lanes 1-4, respectively) was size fraetionated by agarose gel eleetrophoresis, transferred to nitrocellulose and probed 
sequentially with a full-length  lymphoid CD44 eDNA from baboon (93 % homologous  to the human lymphoid sequence, CD44), a hamster 
actin probe (ACT/N), an EACR-speeific  eDNA (EACR), and a CD44 cytoplasmic domain eDNA (CFTO). The EACR-specific  eDNA was 
a 372-bp fragment  corresponding  t  o nueleotides  803-1172 of  the reported sequence.  It  was derived  from an  Rsa I digest of  HFK  cDNA amplified 
by PCR using the SJ1 and HE1 oligonueleotides.  The cytoplasmic  domain  probe was a 140-bp fragment  corresponding  to nueleotides  1022--1162 
of  the  human  lymphoid  sequence  (Stamenkovie  et al., 1989). It  was  derived  by PCR amplitieation  of  HFF  eDNA  using  the SJ2 and  B7-2 oligonucleo- 
tides. Actin hybridization is shown for quantitative comparison of the total poly-A  + RNA loaded in each lane. 
tion with chondroitinase (not shown). This form is therefore 
referred to as HFK HS/CS250. Thus, each cell population 
generated a sulfated form of CD44 with the high molecular 
mass forms expressing differing amounts of heparan sulfate, 
chondroitin sulfate, and other carbohydrate moieties. 
Information about  the  nonglyeosaminoglycan carbohy- 
drates of GP230 and GP90 was obtained by lectin blotting 
and immunoblotting with carbohydrate-specific mAbs (Fig. 
5). Purified GP90 and GP230 (purification of CD44 is dis- 
cussed later under Fig. 10) were fractionated by SDS-PAGE, 
transferred to  nitrocellulose,  incubated with  and  without 
neuraminidase, and reacted with labeled lectins or carbohy- 
drate-specific mAbs. Wheat germ agglutinin reacted strongly 
with both GP90 and GP230 before, but not after, digestion 
with neuraminidase,  indicating the presence  of extensive 
terminal sialylation. Removal of terminal sialic acid from 
HT1080 GP90 and QG56 and GP230 exposed penultimate 
galactose residues detected by binding ofRicinus communis 
agglutinin  (gal-glcNAc preference)  and peanut  agglutinin 
(gal-galNac preference). The binding of the galactose-spe- 
cific lectins was extensive on GP230 and weak on GP90. The 
binding of  peanut agglutinin confirms the presence of ser/thr- 
linked, O-glycosides or mucin-like structures. After desialy- 
lation, GP230 bound the carbohydrate-specific mAb C6, that 
recognizes biantennary binary N-acetyllactosamine, a mini- 
mum polylactosamine structure (Nichols et al.,  1987). 
Identification of  a Distinct Form of CD44 
Core Protein, CD44E 
We initially used pulse-chase labeling with [35S]methionine 
to identify underglycosylated precursors of the fully glyco- 
sylated glyeoproteins (Fig. 6). Two types of precursors were 
identified for the four characterized forms of CIM4. HT1080 
cells exhibit a single 65-kD precursor to GP90 (termed Pre- 
GP90).  In contrast, four precursors to both QG56 GP230 
and HFK HS/CS250 migrated with similar relative molecu- 
lar masses of 90--135 kD (designated GPa-d or HSa-d, re- 
spectively), despite the differences in final glycosylation for 
these two forms. 
Northern blot analysis provided further evidence that the 
core proteins for different CD44 forms may be similar, but 
not identical. A full-length cDNA probe to lymphoid CD44 
detected at least three mRNA species in all cell populations 
examined (Fig. 7). However, epithelial cell types (i.e., HFKs 
and QG56 cells) exhibited major mRNA species between 1.0 
and 1.6 kb longer (2.8, 3.6, and 6.7 kb) than what appeared 
to be their counterparts in fibroblasts (1.8, 2.4, and 5.1 kb). 
Upon longer exposure, the latter set of mRNA species was 
also apparent as minor species in the epithelial cells. It was 
possible that the larger set of mRNA species in these epithe- 
lial cells contained a larger coding region with unique se- 
quences. Therefore, we amplified specific regions of eDNA 
Brown et al. cDNA and Glycosylation  Variants  in Epithelial CD44  215 Figure 8. Analysis of CD44 mRNA species in epithelial and fibroblast cell populations by PCR amplification. (A) Linear map of CD44 
and CD44E mRNAs with positions of oligonueleotides shown. The epithelial-associated coding region (EACR, heavy bar) and transmem- 
brane region (crosshatched bar) are also shown. The untranslated regions (open bars) are taken from Stamenkovic et al. (1989). (B) PCR 
amplification of CD44 eDNA, reverse transcribed from HT1080, HFF and HFK poly-A  ÷ RNA. For each cell type the oligonucleotides 
used were 137-2 and SJ2 (lanes 1), SJ1 (lanes 2), B7-6 (lanes 3), or B7-4 (lanes 4). Results identical to HFK lanes was obtained using 
QG56 eDNA. The eDNA band sequenced is denoted by the arrow. (C) PCR amplification of CD44E eDNA from HFK, but not HFF, 
cells using an EACR-specifie  oligonucleotide, HE2, and transmembrane oligonucleotide D1 (lanes 1) or cytoplasmic oligonucleotide, B7-2 
(lanes 2) PCR amplification of EACR external sequences using B7-2 and SJ2 (lanes 3) or D2 (lanes 4) were included as controls. 
from these cells using the PCR thermocycler with oligonu- 
cleotides specific for various regions of the lymphoid cDNA 
(Fig. 8 A). The reactions enlisted a common downstream or 
3' oligonucleotide (i.e., B7-2 in the cytoplasmic protein do- 
main, Fig. 8 A) coupled with various upstream (i.e., towards 
the extracellular protein domain)  oligonucleotides (Fig.  8 
B). Using the SJ2 oligonueleotide in conjunction with B7-2, 
only one eDNA of predicted length was amplified from both 
fibroblasts and epithelial cells (lanes/), suggesting that this 
region is similar in all transcripts that contain the cytoplas- 
mic domain. When the upstream oligonueleotide B7-6, B7-4, 
or SJI was used in conjunction with 137-2, cDNAs amplified 
from HT1080 cells or HFFS were the same sizes as predicted 
for the lymphoid eDNA sequence. This suggested that the 
fibroblast CD44 eDNA is identical to the lymphoid CD44 
sequence. In contrast, amplification of eDNA from HFKs 
(Fig. 8 B) and QG56 cells (not shown) using the same com- 
binations of oligonueleotides resulted in not only the pre- 
dicted cDNA products from the lymphoid sequence, but also 
several larger cDNA products. As the upstream oligonucleo- 
tide was shifted more towards the 5' end, the epithelial-spe- 
cific eDNA product obtained was uniformly larger. This in- 
dicated that the additional cDNA was inserted between the 
S  J1 and B7-2 oligonucleotides. 
To identify the gel bands containing additional inserted 
cDNA sequences from HFKs and  QG56 ceils,  individual 
DNA bands were excised from the gels, the cDNA isolated 
and used as templates in a subsequent, otherwise identical 
The Journal of Cell Biology, Volume 113,  1991  216 form), resulting in a glycine substitution for a glutamine in 
the amino acid sequence. 
To determine which of the different CD44 mRNA tran- 
scripts contained the EACR sequence, Northern blots were 
probed with a 372-bp fragment contained within the EACR 
sequence (Fig. 7, EACR).  All of the major mRNA species 
identified by the full-length lymphoid probe in QG56 cells 
and HFKs hybridized with the EACR-specific probe. In con- 
trast, none of the major mRNA species in HT1080 ceils or 
HFFs hybridized with the EACR probe. Using a cytoplasmic 
domain eDNA probe, we detected in the epithelial cells not 
only three major CIM4E mRNA species, but also the three 
major lymphoid-associated CIM4 transcripts (Fig. 7, CF/D). 
In addition, all four cell populations express a  1.3-kb tran- 
script similar in size to the cloned CD44 sequence reported 
by Stamenkovic et al.  (1989). 
Figure 9. cDNA and deduced protein sequences of the EACR from 
HFKs and QG56 cells. The EACR, spliced in immediately before 
nucleotide 783 of the human lymphoid sequence (Stamenkovic et 
al.,  1989; the sequence numbers used are relative to this splice 
site), is composed of 396 nueleotides and shown in uppercase. The 
eDNA flanking the EACR (118 bp, 5' and 67 bp, 3') that was se- 
quenced is shown in lower case. Potential O-glycosylation (under- 
line), N-glycosylation (bold underline)  and GAG attachment sites 
(.) are indicated. The eDNA sequence obtained from both cell 
populations was identical and is available from EMBL/Genbank/ 
DDBJ under accession number X55938. 
PCR amplification. The largest PCR product (arrow, Fig. 8 
B), resulted in much greater amplification of itself than the 
smaller lymphoid-associated product.  This suggested that 
the largest product was a new epithelial eDNA product con- 
taminated with minute amounts of  the smaller lymphoid type 
cDNA (data not shown). 
Both  strands  of the  largest band  from both HFKs and 
QG56 cells was sequenced directly using several of the oligo- 
nucleotides in Fig. 8 A as primers. The sequence was identi- 
cal for both cell populations (Fig. 9), and contained an extra 
396  bp  between  the  5'  and  3'  flanking  lymphoid  CD44 
cDNA.  We designated this  extra cDNA the epithelial-as- 
sociated coding region (EACR). Those transcripts that con- 
tain the EACR were designated as CD44E. The EACR was 
spliced into the CD44 mRNA before nucleotide 783 of the 
human sequence (Stamenkovic et al., 1989), the second nu- 
cleotide of the codon. This changed the arginine in the lym- 
phoid form into an asparagine in the epithelial form. The 
EACR was unique in that it showed no significant homology 
to other sequences in the Genbank or EMBL databases (re- 
leases 63 and 23, respectively) and coded for an amino acid 
sequence composed of >30-% serine and threonine residues. 
The cDNA  sequence derived from both flanking  regions 
agreed exactly with one of the reported human lymphoid 
CD44 sequences (Goldstein et al., 1989), and varied by only 
a single base from the other (Stamenkovic et al.,  1989). In 
the latter a G was substituted for an A at nucleotide 831 of 
the lymphoid sequence (nucleotide  1227  of the epithelial 
Figure 10.  Differential extraction, phase partitioning with Triton 
X-114 detergent and purification  of HT1080  GlX)0  and QG56 GP230. 
HT1080 and QG56 cells were  125I-surface labeled,  and sequen- 
tially extracted as previously described (Carter et al., 1982) first, 
with 2 M urea in 1 M NaCI to remove peripherally cell surface 
components, and second, with Triton X-114  (PARTITION) or X-100 
(PURIFY) detergent at 4°C to solubilizc membrane components 
followed by phase partitioning at 37°C for the Triton X-I14 frac- 
tions (Bordier, 1981). The temperature increase results in formation 
of a detergent phase that contains membrane  components with 
dominant hydrophobic character and an aqueous phase with domi- 
nant hydrophilic character. Each Triton X-114-derived  phase was 
immune precipitated with anti-CD44 mAb (P1G12) and the anti- 
gens fractionated by SDS-PAGE followed  by autoradiography. Un- 
labeled Triton  X-100 extracts were used to affinity purify  both 
HTI080  GP90 and QG56 GP230 by chromatography on WGA- 
Sepharose to purify all sialyated membrane glycoproteins followed 
by chromatography of the purified glycoproteins on P1G12-Scpha- 
rose. The bound and eluted GPg0 and GP230 were labeled with 
t25I Iodobcads and fractionated on SDS-PAGE (GP90 on 10%, 
GP230 on 8 %) followed  by autoradiography.  Neither protein stained 
appreciably with Coomassie blue, possibly due to extensive gly- 
cosylation. 
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The GP90 form of CD44 has been previously characterized 
as a transmembrane glycoprotein (Carter and Wayner, 1988) 
and a corresponding hydrophobic transmembrane sequence 
has been identified in the amino acid sequence of the core 
protein  (Idzerda et al.,  1989).  No  such information was 
available  for the related higher molecular mass  forms of 
CD44. We have used PCR amplification of CIM4E eDNA 
from HFKs (Fig. 8 C) and QG56 cells (not shown) to dem- 
onstrate that at least one CD44E transcript includes very 
similar coding sequences for the transmembrane and cyto- 
plasmic domains.  Moreover,  the 2.8-  and 3.6-kb  CIM4E 
transcripts comigrate with a subset of the CD44 transcripts 
detected with a probe from the cytoplasmic domain (Fig. 7, 
EACR and CI'TO).  This suggested that these CD44E tran- 
scripts express cytoplasmic, and presumably hydrophobic 
transmembrane, domains similar to those in CD44. To ana- 
lyze the polymorphic forms of CD44,  we surface labeled 
HT1080 and QG56 cells with ~25I and subjected them to a 
sequential extraction as described in the legend to Fig.  10. 
Immunoprecipitation of the labeled cell extracts or immuno- 
blotting of the unlabeled cell extracts with anti-CD44 mAbs 
detected the CD44 forms primarily in the Triton X-114 ex- 
tract.  As seen in Fig.  10 (Part/t/on), temperature-induced 
phase partitioning of the Triton X-114 extract into detergent 
and aqueous phases further distinguished HT1080 GP90 and 
• QG56 GF230; GP230 was recovered in the aqueous phase 
and as previously reported, GP90 was recovered in the deter- 
gent phase. In results not shown HT1080 CS180 and HFK 
HS/CS250  were recovered primarily in the Triton X-114 
aqueous phase. Thus, all the CD44 forms required detergent 
for solubilization. However, the additional glycosylation  and 
other possible modifications altered the partitioning charac- 
ter of the higher molecular mass forms. 
We further establish that the larger polymorphic forms are 
intrinsic membrane glycoproteins with a  hydrophobic do- 
main that intercalates into the lipid bilayer of the plasma 
membrane.  Unlabeled QG56 GP230 (and HT1080 GP90) 
was purified from Triton X-100 detergent extracts by affinity 
chromatography, and the purified proteins were labeled and 
incorporated into liposomes. Autoradiographs of the puri- 
fied, labeled GP230 (and GP90) detected one major band in 
each preparation after SDS-PAGE (Fig. 10, PURIFY). Lipo- 
somes were prepared in the presence or absence of purified 
GP230. Only those liposomes containing GP230 would bind 
to immobilized anti-CD44 mAbs, indicating that GP230 in- 
corporated into the liposomes in a proper configuration to 
interact with the antibodies (Fable I). 
Discussion 
Peptide and Carbohydrate Polymorphism  in CD44 
We have identified and  characterized  the CIM4 antigen as a 
polymorphic intrinsic membrane proteoglycan/glycoprotein 
with alternate splicing of the core peptide as well as extraor- 
dinary diversity in both the type and quantity of  carbohydrate 
moieties. All the forms of CIM4 contained at least one type 
of sulfated carbohydrate unit as well as nonsulfated carbohy- 
drates. Previous reports relating to the CIM4 have focused 
on hematopoietic ceils (Jalkanen et al., 1988;  Goldstein et 
Table L Incorporation of  Purified GP230 
from QG56 Cells into Liposomes: 
GP230 Is an Intrinsic Membrane Glycoprotein 
Adhesive surface  Liposomes +  GP230  Liposomes -  GP230 
BSA  516  644 
IgG  594  681 
P3H9  7,612  58 
GP230 was purified as described in Fig.  10 and then incorporated into lipo- 
somes prepared  from  [3H]phospbafidyleholine,  unlabeled  egg  yolk  phos- 
phatidyleholine,  and octylglucoside detergent by dialysis (Mimm~ et al., 1981; 
Pytela et al., 1985). The labeled liposomes prepared with and without GP230 
were incubated with plastic surfaces that had been coated with anti-CD44 anti- 
body (P3H9) or control IgG and BSA (Carter and Wayner, 1988). The bound 
liposomes were solubilized and quantitated  in a scintillation counter. 
al., 1989;  Stamenkovic et al., 1989;  Pals et al., 1989) and 
have identified chondroitin sulfate as a carbohydrate moiety 
of the relatively minor higher molecular mass forms. The 
present study has established that epithelial ceils, in particu- 
lar, express the higher molecular mass forms as the major 
species of  CIM4. Glycosylation  of  these forms can be unique 
for each cell type with heparan sulfate being the major car- 
bohydrate derivative of epidermal cells. Glycosylation  of the 
related core proteins may reflect major differences in the 
glycosylation pathways of the individual cells and/or func- 
tional differences for the polymorphic forms (Paulson, 1989). 
Others have reported cell-type specific polymorphic forms 
of cell surface proteogiycans such as syndecan (Sanderson 
and Bernfield, 1988). Based on eDNA sequences, however, 
CD44E and human syndecan (Mali et al.,  1990) have un- 
related core proteins. 
Lymphoid and mesenchymal cells  express  three major 
mRNA species for CIM4, all presumably coding for a 37-kD 
core protein (Idzerda et al., 1989; Stamenkovic et al., 1989). 
In contrast, HFKs and QG56 cells express mRNA species 
for an alternate core protein, CD44E, in addition to the three 
mRNAs for CIM4. The CD44E mRNAs code for a core pro- 
tein with an additional 14 kD inserted in the extracellular do- 
main that we have designated the EACR. The DNA sequence 
flanking the EACR was identical to that previously reported 
for the lymphoid  core protein. Thus, the CD44E mRNA spe- 
cies probably arise from alternative splicing of a common 
gene rather than the use of an alternate CD44E gene. 
The extra 132 amino acids in the CD44E core protein are 
spliced in the region near the COOH-terminal portion of the 
extracellular domain. The sequence flanking the splice site 
contains four repeats of  the SGXG motif (Stamenkovic et al., 
1989; Goldstein et al., 1989), a presumptive attachment site 
for chondroitin sulfate chains (Bourdon et al., 1987). Inter- 
estingly, the EACR is inserted in between these SGXG re- 
peats and contains only one additional SG dipeptide at the 
COOH terminus. This extra repeat is a poor candidate for 
a  chondroitin sulfate attachment site,  though, because  it 
contains neither upstream acidic residues nor the complete 
SGXG motif described by Bourdon et al. (1987).  However, 
five potential O-glycosylation  sites composed of  at least three 
consecutive serine or threonine residues (Tomita et al., 1978) 
are found in the EACR sequence, adding to three similar 
sites in the flanking regions. Thus, QG56 ceils may use these 
sites for the attachment of O-linked carbohydrate chains to 
GP250.  The presence of heparan sulfate chains on the HFK 
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other forms of CD44, suggests that the EACR sequence may 
also contain as yet undescribed heparan sulfate attachment 
sites. Alternatively, the presence of the EACR may induce 
a  new  protein  conformation exposing  distant and previ- 
ously buried heparan sulfate attachment sites in the flanking 
regions. 
The expression of CD44E mRNAs by HFKs and QG56 
cells correlated with the observation by pulse/chase labeling 
of  higher  mass  precursors.  QG56  GP230  and  HFK 
HS/CS250 appear to originate from precursors that were dis- 
tinct from the 65-kD HTI080 GP90 precursor. The QG56 
and HFK precursors were similar, if not identical, despite 
the differences in final glycosylation. Nevertheless, we can- 
not conclude that the GP230 and HS/CS250 forms contain 
the CD44E core protein since mRNA species for both core 
proteins are expressed by these cells. 
HT1080 GP90 contains a phosphorylated cytoplasmic do- 
main that is Inked to the glycosylated extracellular domain 
by a transmembrane hydrophobic sequence of amino acids 
based on both biochemical (Carter and Wayner, 1988) and 
cDNA sequence data (Idzerda et al., 1989; Stamenkovic et 
al., 1989). Similarly, the QG56 GP230 and HFK HS/CS250 
beth  required  detergent  (but  not  high  salt  or  urea)  for 
solubilization and could be incorporated into liposomes, in- 
dicating the presence of a dominant hydrophobic domain. 
Moreover, at least two of the CD44E mRNA species codes 
for transmembrane and cytoplasmic domains very similar, 
if not  identical,  to  the  CIM4  core  proteins  previously 
reported in lymphoid cells. This observation suggests that 
the CIM4E core protein expressed by these mRNA species 
is not part of a form destined for secretion and may be used 
in the HFK HS/CS250 and QG56 GP230 forms. In addition, 
these CIM4E core proteins would be expected to have simi- 
lar associations with intracellular components, unlike the 
core protein reported by Goldstein et al. (1989)  that lacks 
most of the cytoplasmic domain. 
Functional Role for CD44 in Cell Adhesion 
Filopodia have been  suggested to be directly involved in 
initial  cell-cell  and  cell-substratum  contacts  (Albrecht- 
Buehler et al., 1976).  CD44 localizes in filopodia that con- 
tact with the substrate and in cell-cell contact sites suggest- 
ing that CD44 may form weak initial cell interactions. CD44 
does not appear to be a cell-substrate adhesion receptor for 
collagen, fibronectin, or laminin (Wayner and Carter, 1987; 
Carter and Wayner, 1988).  This conclusion is based on the 
absence of CD44 in focal adhesions, a major site of stable 
cell adhesion, and the inability of anti-CD44 antibodies to 
inhibit cell adhesion to ECM ligands. However, CD44 is an 
intrinsic membrane proteoglycan, a  group of macromole- 
cules that have been proposed as mediators of cell-substrate 
adhesion  (Cole  et al.,  1985;  Koda and Bernfield,  1984; 
Laterra et al., 1983; Woods et al., 1984,  1985; LeBaron et 
al., 1988;  Ruoslahti, 1988).  We have recently identified an 
alternate adhesion structure, termed a stable anchoring con- 
tact (SAC; Carter et al., 1990b).  The possibility that CD44 
interacts with SACs and/or other adhesion structures is cur- 
rently under investigation. As a possible mechanism, CD44 
expresses a partial sequence homology with mouse link pro- 
tein (Idzerda et al.,  1989;  Goldstein et al.,  1989;  Stamen- 
kovic et al., 1989). Link protein stabilizes the interaction of 
hyaluronate with the core protein of proteoglycans in carti- 
lage (Neame et al., 1987). Recently, hyaluronate was shown 
to be a possible ligand for CD44  (Miyake et al.,  1990b; 
Aruffo et al.,  1990). 
The possible role of CIM4 in mediating cell adhesion may 
make use of the variability in carbohydrate content.  The 
presence of  major amounts of glycosaminoglycan  on the core 
protein of HS/CS250 may modulate cell-cell interactions 
directly or via components of the extracellular matrix. Nor- 
real differentiation, stratification as well as abnormal lesions 
of epithelium  have  been  reported  to  correlate  with  the 
differential expression  of carbohydrate structures  in  skin 
(Dabelstein  et  al.,  1986).  CD44  is  one  of  the  major 
glycoconjngates of differentiating epidermis and exhibits an 
extraordinary sensitivity to regulation in carbohydrate con- 
tent. This suggests a possible regulatory role for glycosyla- 
tion in the function of CD44 in epidermis. Whether or not 
CD44 is primarily an adhesive glycoconjugate, its extensive 
polymorphism in both protein and carbohydrate dictate that 
care is required to identify  the CD44 isoform responsible for 
a particular event when examining functional corollaries. 
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